Report Detail
Global Attention Deficit Hyperactivity Disorder (ADHD) Supply, Demand and Key Producers, 2026-2032
- RnM4666822 |
- 22 January, 2026 |
- Global |
- 121 Pages |
- GIR |
- Pharma & Healthcare
The global Attention Deficit Hyperactivity Disorder (ADHD) market size is expected to reach $ 19800 million by 2032, rising at a market growth of 4.8% CAGR during the forecast period (2026-2032).
Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.
The ADHD market is expanding rapidly due to rising global awareness and increasing diagnosis rates, especially in children and young adults. Improved understanding of mental health conditions among healthcare providers, educators, and parents has contributed to earlier identification and more proactive treatment approaches. Government-supported initiatives, mental health screenings in schools, and expanded insurance coverage have made ADHD treatment more accessible in both developed and developing regions. Furthermore, advancements in pharmacological research have led to the availability of more effective, long-acting, and better-tolerated medications, expanding the range of treatment options. The rise of digital health platforms, including telemedicine and mobile apps for symptom monitoring, has also made ADHD management more convenient and efficient. Growing adult ADHD diagnosis, driven by increased public discussion and reduced stigma, is further contributing to market growth.
Despite the increasing demand, the ADHD market faces several significant challenges. One of the main concerns is the potential overdiagnosis or misdiagnosis of ADHD, particularly in children, leading to inappropriate or excessive use of medications. Differentiating ADHD from other behavioral or psychological disorders like anxiety, autism, or learning disabilities remains complex, often requiring multidisciplinary assessments. Medication side effects, such as insomnia, appetite suppression, and cardiovascular concerns, can lead to treatment non-compliance or discontinuation. There are also regulatory barriers around stimulant drug prescriptions due to their potential for abuse and dependency. Additionally, disparities in healthcare infrastructure and limited access to trained mental health professionals in low-income and rural areas hinder timely diagnosis and treatment. Cultural stigma around psychiatric disorders still discourages many individuals and families from seeking medical help, especially in emerging markets.
This report studies the global Attention Deficit Hyperactivity Disorder (ADHD) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Attention Deficit Hyperactivity Disorder (ADHD), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Attention Deficit Hyperactivity Disorder (ADHD) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Attention Deficit Hyperactivity Disorder (ADHD) total market, 2021-2032, (USD Million)
Global Attention Deficit Hyperactivity Disorder (ADHD) total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Attention Deficit Hyperactivity Disorder (ADHD) total market, key domestic companies, and share, (USD Million)
Global Attention Deficit Hyperactivity Disorder (ADHD) revenue by player, revenue and market share 2021-2026, (USD Million)
Global Attention Deficit Hyperactivity Disorder (ADHD) total market by Type, CAGR, 2021-2032, (USD Million)
Global Attention Deficit Hyperactivity Disorder (ADHD) total market by Distribution Channel, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Attention Deficit Hyperactivity Disorder (ADHD) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Attention Deficit Hyperactivity Disorder (ADHD) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Distribution Channel. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Attention Deficit Hyperactivity Disorder (ADHD) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Attention Deficit Hyperactivity Disorder (ADHD) Market, Segmentation by Type:
Stimulant
Non-stimulant
Global Attention Deficit Hyperactivity Disorder (ADHD) Market, Segmentation by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Companies Profiled:
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Zhengdafenhai
Highland Therapeutics
Jubilant Life Sciences
Medice Arzneimittel Putter
Lannett
Key Questions Answered
1. How big is the global Attention Deficit Hyperactivity Disorder (ADHD) market?
2. What is the demand of the global Attention Deficit Hyperactivity Disorder (ADHD) market?
3. What is the year over year growth of the global Attention Deficit Hyperactivity Disorder (ADHD) market?
4. What is the total value of the global Attention Deficit Hyperactivity Disorder (ADHD) market?
5. Who are the Major Players in the global Attention Deficit Hyperactivity Disorder (ADHD) market?
6. What are the growth factors driving the market demand?
1 Supply Summary
- 1.1 Attention Deficit Hyperactivity Disorder (ADHD) Introduction
- 1.2 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size & Forecast (2021 & 2025 & 2032)
- 1.3 World Attention Deficit Hyperactivity Disorder (ADHD) Total Market by Region (by Headquarter Location)
- 1.3.1 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2021-2032), (by Headquarter Location)
- 1.3.2 United States Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2021-2032)
- 1.3.3 China Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2021-2032)
- 1.3.4 Europe Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2021-2032)
- 1.3.5 Japan Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2021-2032)
- 1.3.6 South Korea Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2021-2032)
- 1.3.7 ASEAN Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2021-2032)
- 1.3.8 India Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2021-2032)
- 1.4 Market Drivers, Restraints and Trends
- 1.4.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
- 1.4.2 Factors Affecting Demand
- 1.4.3 Major Market Trends
2 Demand Summary
- 2.1 World Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2021-2032)
- 2.2 World Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region
- 2.2.1 World Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region (2021-2026)
- 2.2.2 World Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Forecast by Region (2027-2032)
- 2.3 United States Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2021-2032)
- 2.4 China Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2021-2032)
- 2.5 Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2021-2032)
- 2.6 Japan Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2021-2032)
- 2.7 South Korea Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2021-2032)
- 2.8 ASEAN Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2021-2032)
- 2.9 India Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2021-2032)
3 World Attention Deficit Hyperactivity Disorder (ADHD) Companies Competitive Analysis
- 3.1 World Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Player (2021-2026)
- 3.2 Industry Rank and Concentration Rate (CR)
- 3.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Industry Rank of Major Players
- 3.2.2 Global Concentration Ratios (CR4) for Attention Deficit Hyperactivity Disorder (ADHD) in 2025
- 3.2.3 Global Concentration Ratios (CR8) for Attention Deficit Hyperactivity Disorder (ADHD) in 2025
- 3.3 Attention Deficit Hyperactivity Disorder (ADHD) Company Evaluation Quadrant
- 3.4 Attention Deficit Hyperactivity Disorder (ADHD) Market: Overall Company Footprint Analysis
- 3.4.1 Attention Deficit Hyperactivity Disorder (ADHD) Market: Region Footprint
- 3.4.2 Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Type Footprint
- 3.4.3 Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Application Footprint
- 3.5 Competitive Environment
- 3.5.1 Historical Structure of the Industry
- 3.5.2 Barriers of Market Entry
- 3.5.3 Factors of Competition
- 3.6 Mergers & Acquisitions Activity
4 United States VS China VS Rest of World (by Headquarter Location)
- 4.1 United States VS China: Attention Deficit Hyperactivity Disorder (ADHD) Revenue Comparison (by Headquarter Location)
- 4.1.1 United States VS China: Attention Deficit Hyperactivity Disorder (ADHD) Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
- 4.1.2 United States VS China: Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share Comparison (2021 & 2025 & 2032)
- 4.2 United States Based Companies VS China Based Companies: Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Comparison
- 4.2.1 United States VS China: Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Comparison (2021 & 2025 & 2032)
- 4.2.2 United States VS China: Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
- 4.3 United States Based Attention Deficit Hyperactivity Disorder (ADHD) Companies and Market Share, 2021-2026
- 4.3.1 United States Based Attention Deficit Hyperactivity Disorder (ADHD) Companies, Headquarters (States, Country)
- 4.3.2 United States Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue, (2021-2026)
- 4.4 China Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Market Share, 2021-2026
- 4.4.1 China Based Attention Deficit Hyperactivity Disorder (ADHD) Companies, Company Headquarters (Province, Country)
- 4.4.2 China Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue, (2021-2026)
- 4.5 Rest of World Based Attention Deficit Hyperactivity Disorder (ADHD) Companies and Market Share, 2021-2026
- 4.5.1 Rest of World Based Attention Deficit Hyperactivity Disorder (ADHD) Companies, Headquarters (Province, Country)
- 4.5.2 Rest of World Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2021-2026)
5 Market Analysis by Type
- 5.1 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size Overview by Type: 2021 VS 2025 VS 2032
- 5.2 Segment Introduction by Type
- 5.2.1 Stimulant
- 5.2.2 Non-stimulant
- 5.3 Market Segment by Type
- 5.3.1 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2021-2026)
- 5.3.2 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2027-2032)
- 5.3.3 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2027-2032)
6 Market Analysis by Distribution Channel
- 6.1 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size Overview by Distribution Channel: 2021 VS 2025 VS 2032
- 6.2 Segment Introduction by Distribution Channel
- 6.2.1 Hospital Pharmacy
- 6.2.2 Retail Pharmacy
- 6.3 Market Segment by Distribution Channel
- 6.3.1 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2021-2026)
- 6.3.2 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2027-2032)
- 6.3.3 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel (2021-2032)
7 Company Profiles
- 7.1 Takeda
- 7.1.1 Takeda Details
- 7.1.2 Takeda Major Business
- 7.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.1.4 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.1.5 Takeda Recent Developments/Updates
- 7.1.6 Takeda Competitive Strengths & Weaknesses
- 7.2 Johnson & Johnson
- 7.2.1 Johnson & Johnson Details
- 7.2.2 Johnson & Johnson Major Business
- 7.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.2.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.2.5 Johnson & Johnson Recent Developments/Updates
- 7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
- 7.3 Novartis
- 7.3.1 Novartis Details
- 7.3.2 Novartis Major Business
- 7.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.3.4 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.3.5 Novartis Recent Developments/Updates
- 7.3.6 Novartis Competitive Strengths & Weaknesses
- 7.4 Eli Lilly
- 7.4.1 Eli Lilly Details
- 7.4.2 Eli Lilly Major Business
- 7.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.4.4 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.4.5 Eli Lilly Recent Developments/Updates
- 7.4.6 Eli Lilly Competitive Strengths & Weaknesses
- 7.5 Tris Pharma
- 7.5.1 Tris Pharma Details
- 7.5.2 Tris Pharma Major Business
- 7.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.5.4 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.5.5 Tris Pharma Recent Developments/Updates
- 7.5.6 Tris Pharma Competitive Strengths & Weaknesses
- 7.6 Neos Therapeutics
- 7.6.1 Neos Therapeutics Details
- 7.6.2 Neos Therapeutics Major Business
- 7.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.6.4 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.6.5 Neos Therapeutics Recent Developments/Updates
- 7.6.6 Neos Therapeutics Competitive Strengths & Weaknesses
- 7.7 Mallinckrodt
- 7.7.1 Mallinckrodt Details
- 7.7.2 Mallinckrodt Major Business
- 7.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.7.4 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.7.5 Mallinckrodt Recent Developments/Updates
- 7.7.6 Mallinckrodt Competitive Strengths & Weaknesses
- 7.8 Amneal Pharmaceuticals
- 7.8.1 Amneal Pharmaceuticals Details
- 7.8.2 Amneal Pharmaceuticals Major Business
- 7.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.8.4 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.8.5 Amneal Pharmaceuticals Recent Developments/Updates
- 7.8.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
- 7.9 Noven Pharmaceuticals
- 7.9.1 Noven Pharmaceuticals Details
- 7.9.2 Noven Pharmaceuticals Major Business
- 7.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.9.4 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.9.5 Noven Pharmaceuticals Recent Developments/Updates
- 7.9.6 Noven Pharmaceuticals Competitive Strengths & Weaknesses
- 7.10 Purdue Parma
- 7.10.1 Purdue Parma Details
- 7.10.2 Purdue Parma Major Business
- 7.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.10.4 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.10.5 Purdue Parma Recent Developments/Updates
- 7.10.6 Purdue Parma Competitive Strengths & Weaknesses
- 7.11 Zhengdafenhai
- 7.11.1 Zhengdafenhai Details
- 7.11.2 Zhengdafenhai Major Business
- 7.11.3 Zhengdafenhai Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.11.4 Zhengdafenhai Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.11.5 Zhengdafenhai Recent Developments/Updates
- 7.11.6 Zhengdafenhai Competitive Strengths & Weaknesses
- 7.12 Highland Therapeutics
- 7.12.1 Highland Therapeutics Details
- 7.12.2 Highland Therapeutics Major Business
- 7.12.3 Highland Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.12.4 Highland Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.12.5 Highland Therapeutics Recent Developments/Updates
- 7.12.6 Highland Therapeutics Competitive Strengths & Weaknesses
- 7.13 Jubilant Life Sciences
- 7.13.1 Jubilant Life Sciences Details
- 7.13.2 Jubilant Life Sciences Major Business
- 7.13.3 Jubilant Life Sciences Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.13.4 Jubilant Life Sciences Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.13.5 Jubilant Life Sciences Recent Developments/Updates
- 7.13.6 Jubilant Life Sciences Competitive Strengths & Weaknesses
- 7.14 Medice Arzneimittel Putter
- 7.14.1 Medice Arzneimittel Putter Details
- 7.14.2 Medice Arzneimittel Putter Major Business
- 7.14.3 Medice Arzneimittel Putter Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.14.4 Medice Arzneimittel Putter Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.14.5 Medice Arzneimittel Putter Recent Developments/Updates
- 7.14.6 Medice Arzneimittel Putter Competitive Strengths & Weaknesses
- 7.15 Lannett
- 7.15.1 Lannett Details
- 7.15.2 Lannett Major Business
- 7.15.3 Lannett Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
- 7.15.4 Lannett Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2021-2026)
- 7.15.5 Lannett Recent Developments/Updates
- 7.15.6 Lannett Competitive Strengths & Weaknesses
8 Industry Chain Analysis
- 8.1 Attention Deficit Hyperactivity Disorder (ADHD) Industry Chain
- 8.2 Attention Deficit Hyperactivity Disorder (ADHD) Upstream Analysis
- 8.3 Attention Deficit Hyperactivity Disorder (ADHD) Midstream Analysis
- 8.4 Attention Deficit Hyperactivity Disorder (ADHD) Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
- 10.1 Methodology
- 10.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Attention Deficit Hyperactivity Disorder (ADHD). Industry analysis & Market Report on Attention Deficit Hyperactivity Disorder (ADHD) is a syndicated market report, published as Global Attention Deficit Hyperactivity Disorder (ADHD) Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Attention Deficit Hyperactivity Disorder (ADHD) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
